Chief Medical Officer, Dana-Farber Cancer Institute
Oncology
Dr. Craig A. Bunnell, MD
|
|
Give Review
Craig A. Bunnell practices Oncology. He researched medicine at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He has 1 awards "Super Doctor". Craig Bunnell is a published physician. He has 15 papers published. The most current publication "Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Understanding process-of-care delays in surgical treatment of breast Cancer at a comprehensive Cancer center.
- Use of Potassium Concentrations as a Quality-of-Service Metric for Phlebotomists Detects Systematic Preanalytical Biases and Facilitates Their Correction.
- Measuring Opportunities to Improve Timeliness of Breast Cancer Care at Dana-Farber/Brigham and Women's Cancer Center.
- A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast Cancer.
- High performance teamwork training and systems redesign in outpatient oncology.
- Will we be able to care for Cancer patients in the future?
- Models of multidisciplinary Cancer care: physician and patient perceptions in a comprehensive Cancer center.
- Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast Cancer.
- Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast Cancer.
- Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast Cancer chemotherapy.
- Assessment of a dietary questionnaire in Cancer patients receiving cytotoxic chemotherapy.
- Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast Cancer: multicenter phase II trial with clinical outcomes, analysis of seru...
- Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast Cancer...
- Lumping versus splitting: the splitters take this round.
Schools
Harvard Medical School
Brigham and Women39s Hospital
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Breast Cancer
- Cervical Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Super Doctor
Education
-
Brigham and Women's Hospital -
Harvard School of Public Health -
Harvard Medical School
Hospital
-
Massachusetts General Hospital -
Dana-Farber Cancer Institute -
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1982679767 | |
| NPPES Provider LastName | BUNNELL | |
| NPPES Provider FirstName | CRAIG | |
| NPPES Provider ZIPCode | 02115 | |
| NPPES Provider State | MA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 106.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982679767 |
| Last Name Of The Provider | BUNNELL |
| First Name Of The Provider | CRAIG |
| View All |
Similar Doctors
|
|
Dr. Othon Iliopoulos, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen M. Rothenberg, MD
This Doctor is OpenDoctor Recommended.
|